Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Rheolytic therapy combined with intragraft abciximab for treatment in acute myocardial infarction.

Vallakati A, Mastrine L, Ayzenberg S.

J Invasive Cardiol. 2013 Feb;25(2):E33-5.

PMID:
23388236
[PubMed - indexed for MEDLINE]
Free Article
2.

Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.

Brener SJ, Witzenbichler B, Maehara A, Dizon J, Fahy M, El-Omar M, Dambrink JH, Genereux P, Mehran R, Oldroyd K, Parise H, Gibson CM, Stone GW.

Am Heart J. 2013 Jul;166(1):64-70. doi: 10.1016/j.ahj.2013.03.029. Epub 2013 Apr 30.

PMID:
23816023
[PubMed - indexed for MEDLINE]
3.

Randomized comparison of eptifibatide versus abciximab in primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results of the EVA-AMI Trial.

Zeymer U, Margenet A, Haude M, Bode C, Lablanche JM, Heuer H, Schröder R, Kropff S, Bourkaib R, Banik N, Zahn R, Teiger E.

J Am Coll Cardiol. 2010 Aug 3;56(6):463-9. doi: 10.1016/j.jacc.2009.08.093.

PMID:
20670755
[PubMed - indexed for MEDLINE]
Free Article
4.

Comparison between glycoprotein IIb/IIIa blockade and distal protection device for the restoration of myocardial perfusion during percutaneous coronary intervention for acute myocardial infarction.

Mak KH, Phay C, Wong A, Kwok V, Tan KS, Lau KW, Koh TH.

J Invasive Cardiol. 2004 Dec;16(12):694-8.

PMID:
15596872
[PubMed - indexed for MEDLINE]
5.

Emergency coronary artery bypass grafting in patients with acute myocardial infarction treated with glycoprotein IIb/IIIa receptor inhibitors.

De Carlo M, Maselli D, Cortese B, Ciabatti N, Gistri R, Levantino M, Balbarini A, De Caterina R, Petronio AS.

Int J Cardiol. 2008 Jan 24;123(3):229-33. Epub 2007 Apr 11. Review.

PMID:
17433463
[PubMed - indexed for MEDLINE]
6.

Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Shimada YJ, Nakra NC, Fox JT, Kanei Y.

Am J Cardiol. 2012 Mar 1;109(5):624-8. doi: 10.1016/j.amjcard.2011.10.016. Epub 2011 Dec 5. Review.

PMID:
22152971
[PubMed - indexed for MEDLINE]
7.

Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction.

Desch S, Siegemund A, Scholz U, Adam N, Eitel I, de Waha S, Fürnau G, Lurz P, Wetzel S, Schuler G, Thiele H.

Clin Res Cardiol. 2012 Feb;101(2):117-24. doi: 10.1007/s00392-011-0372-6. Epub 2011 Oct 21.

PMID:
22015616
[PubMed - indexed for MEDLINE]
9.
10.

Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.

Di Pasquale P, Cannizzaro S, Scalzo S, Maringhini G, Vitrano GM, Giubilato A, Giambanco F, Sarullo FM, Paterna S.

Int J Cardiol. 2003 Dec;92(2-3):265-70.

PMID:
14659863
[PubMed - indexed for MEDLINE]
11.

Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts.

Barsness GW, Buller C, Ohman EM, Schechter E, Pucillo A, Taylor MA, Miller MJ, Reiner JS, Churchill D, Chandler AB, Gonzalez M, Smith J, Tommaso C, Berdan LG, Wildermann NM, Hasdai D, Holmes DR Jr.

Am Heart J. 2000 May;139(5):824-9.

PMID:
10783216
[PubMed - indexed for MEDLINE]
12.

Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators.

Antman EM, Gibson CM, de Lemos JA, Giugliano RP, McCabe CH, Coussement P, Menown I, Nienaber CA, Rehders TC, Frey MJ, Van der Wieken R, Andresen D, Scherer J, Anderson K, Van de Werf F, Braunwald E.

Eur Heart J. 2000 Dec;21(23):1944-53.

PMID:
11071800
[PubMed - indexed for MEDLINE]
Free Article
13.

Restoration of coronary blood flow by single bolus injection of the GPIIb/IIIa receptor antagonist c7E3 Fab in a patient with acute myocardial infarction of recent onset.

Domanovits H, Nikfardjam M, Janata K, Hornykewycz S, Maurer G, Laggner AN, Huber K.

Clin Cardiol. 1998 Jul;21(7):525-8.

PMID:
9669064
[PubMed - indexed for MEDLINE]
14.

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Ernst NM, Suryapranata H, Miedema K, Slingerland RJ, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Zijlstra F, van 't Hof AW.

J Am Coll Cardiol. 2004 Sep 15;44(6):1187-93.

PMID:
15364318
[PubMed - indexed for MEDLINE]
Free Article
15.

Comparison of abciximab and eptifibatide on angiographic and clinical outcomes in rescue percutaneous coronary intervention for failed fibrinolytic therapy.

Bajaj RR, Mohammad A, Hong T, Irfan A, Sharieff W, Bagnall A, Christie JA, Kutryk MJ, Chisholm RJ, Cheema AN.

J Invasive Cardiol. 2010 Aug;22(8):347-52.

PMID:
20679668
[PubMed - indexed for MEDLINE]
Free Article
16.

[Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].

Auer J, Berent R, Lassnig E, Weber T, Maurer E, Eber B.

Herz. 2003 Aug;28(5):393-403. Review. German.

PMID:
12928738
[PubMed - indexed for MEDLINE]
17.

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial.

Thiele H, Wöhrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, Neuhaus P, Brosteanu O, Sick P, Wiemer M, Kerber S, Kleinertz K, Eitel I, Desch S, Schuler G.

Lancet. 2012 Mar 10;379(9819):923-31. doi: 10.1016/S0140-6736(11)61872-2. Epub 2012 Feb 21.

PMID:
22357109
[PubMed - indexed for MEDLINE]
18.

Early abciximab administration in acute myocardial infarction treated with primary coronary intervention.

Bellandi F, Maioli M, Leoncini M, Toso A, Dabizzi RP.

Int J Cardiol. 2006 Mar 22;108(1):36-42. Epub 2005 May 31.

PMID:
15927285
[PubMed - indexed for MEDLINE]
19.

Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry.

Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, Mielecki W, Depukat R, Janzon M, Stefaniak J, Zmudka K, Dubiel JS, Partyka L, Dudek D.

Am Heart J. 2009 Oct;158(4):569-75. doi: 10.1016/j.ahj.2009.08.008.

PMID:
19781416
[PubMed - indexed for MEDLINE]
20.

Assessment of early administration of abciximab in acute ST-segment elevation myocardial infarction in the emergency room.

Arhan A, Ecollan P, Madonna-Py B, Kergueno J, Bennaceur M, Josse MO, Montalescot G, Riou B.

Presse Med. 2006 Jan;35(1 Pt 1):45-50.

PMID:
16462663
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk